Salas Eduardo Rene 4

4 · ADMA BIOLOGICS, INC. · Filed Feb 11, 2026

AI-generated summary of this filing

Updated Feb 12, 2026

ADMA BIOLOGICS (ADMA) Director Eduardo Salas Receives RSU Award

What Happened

Eduardo Rene Salas, a director of ADMA BIOLOGICS (ADMA), received equity awards on February 9, 2026: 10,690 restricted stock units (RSUs) and an additional 17,730 RSU-type derivative awards, for a total of 28,420 units. The awards were granted at $0.00 (no cash exchanged). The RSUs vest in installments over one year (see footnotes).

Key Details

Transaction date: February 9, 2026; Form 4 filed February 11, 2026 (appears timely—filed within two business days).
Grant amounts/prices: 10,690 RSUs @ $0.00 (award); 17,730 derivative RSUs @ $0.00 (award/derivative).
Vesting: Footnote F1—these RSUs vest in two equal installments at the 6- and 12-month anniversaries of grant (fully vested at one year, subject to continued service).
Shares/units reported after the transaction (per footnote F2): includes the 10,690 RSUs granted 2/9/2026 (vest by 2/9/2027), 5,445 remaining RSUs from a 2/19/2025 grant (vest 2/19/2026), and 5,444 shares of common stock owned by Mr. Salas.
No cash proceeds (not a purchase or sale); this is an equity compensation grant.
Footnote F3 notes other option vesting schedules (monthly over one year) for relevant awards, though no option exercise was reported in this filing.

Context

RSUs are deferred equity awards that convert into shares only when they vest; they are compensation, not a market purchase or sale. Because no shares were sold or bought on the open market, this filing is not a liquidity signal but rather routine director compensation subject to service-based vesting.

Form 4

Period: 2026-02-09

Director

Transactions

Award
Common Stock
[F1][F2]
2026-02-09+10,690→ 21,579 total
Award
Stock Option (Right to Buy)
[F3]
2026-02-09+17,730→ 17,730 total
Exercise: $16.37Exp: 2036-02-09→ Common Stock (17,730 underlying)

Footnotes (3)

[F1]These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the Reporting Person's continued service as of the applicable vesting date.
[F2]Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026, which will fully vest on February 9, 2027, subject to the Reporting Person's continued service as of such vesting date; (ii) 5,445 RSUs out of 10,889 RSUs granted on February 19, 2025, which will vest fully on February 19, 2026, subject to the Reporting Person's continued service as of such vesting date; and (iii) 5,444 shares of common stock owned by the Reporting Person.
[F3]These options vest in twelve equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.

Signature

/s/ Eduardo Rene Salas, by Michael A. Goldstein as attorney-in-fact|2026-02-11

1 file